Xylem Inc. (XYL)
NYSE: XYL · Real-Time Price · USD
120.50
+0.75 (0.63%)
Jul 27, 2026, 1:56 PM EDT - Market open
Xylem Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 808 | 1,479 | 1,121 | 1,019 | 944 | 1,349 |
Cash & Short-Term Investments | 808 | 1,479 | 1,121 | 1,019 | 944 | 1,349 |
Cash Growth | -23.70% | 31.94% | 10.01% | 7.95% | -30.02% | -28.05% |
Accounts Receivable | 1,796 | 1,759 | 1,668 | 1,617 | 1,096 | 953 |
Inventory | 991 | 983 | 996 | 1,018 | 799 | 700 |
Other Current Assets | 435 | 420 | 313 | 230 | 173 | 158 |
Total Current Assets | 4,030 | 4,641 | 4,098 | 3,884 | 3,012 | 3,160 |
Net Property, Plant & Equipment | 1,151 | 1,159 | 1,152 | 1,169 | 630 | 644 |
Other Intangible Assets | 2,213 | 2,272 | 2,379 | 2,529 | 930 | 1,016 |
Goodwill | 8,292 | 8,332 | 7,980 | 7,587 | 2,719 | 2,792 |
Other Long-Term Assets | 1,268 | 1,230 | 884 | 943 | 661 | 664 |
Total Assets | 16,954 | 17,634 | 16,493 | 16,112 | 7,952 | 8,276 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 969 | 1,013 | 1,006 | 968 | 723 | 639 |
Accrued Expenses | 1,182 | 1,237 | 1,271 | 1,221 | 867 | 752 |
Short-Term Debt | 531 | 534 | 38 | 16 | - | - |
Other Current Liabilities | 73 | 72 | 21 | - | - | - |
Total Current Liabilities | 2,755 | 2,856 | 2,336 | 2,205 | 1,590 | 1,391 |
Long-Term Debt | 1,407 | 1,408 | 1,978 | 2,268 | 1,880 | 2,440 |
Other Long-Term Liabilities | 1,563 | 1,621 | 1,297 | 1,463 | 979 | 1,219 |
Total Long-Term Liabilities | 2,970 | 3,029 | 3,275 | 3,731 | 2,859 | 3,659 |
Total Liabilities | 5,725 | 5,885 | 5,611 | 5,936 | 4,449 | 5,050 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 3 | 3 | 3 | 3 | 2 | 2 |
Treasury Stock | -1,368 | -768 | -753 | -733 | -708 | -656 |
Additional Paid-in Capital | 8,772 | 8,759 | 8,687 | 8,564 | 2,134 | 2,089 |
Accumulated Other Comprehensive Income | -229 | -220 | -435 | -269 | -226 | -371 |
Retained Earnings | 3,794 | 3,706 | 3,140 | 2,601 | 2,292 | 2,154 |
Total Common Shareholders' Equity | 10,972 | 11,480 | 10,642 | 10,166 | 3,494 | 3,218 |
Minority Interest | 257 | 269 | 240 | 10 | 9 | 8 |
Shareholders' Equity | 11,229 | 11,749 | 10,882 | 10,176 | 3,503 | 3,226 |
Total Liabilities & Equity | 16,954 | 17,634 | 16,493 | 16,112 | 7,952 | 8,276 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1,938 | 1,942 | 2,016 | 2,284 | 1,880 | 2,440 |
Net Cash (Debt) | -1,130 | -463 | -895 | -1,265 | -936 | -1,091 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -4.63 | -1.90 | -3.68 | -5.80 | -5.17 | -6.01 |
Book Value | 10,972 | 11,480 | 10,642 | 10,166 | 3,494 | 3,218 |
Book Value Per Share | 44.98 | 47.05 | 43.70 | 46.59 | 19.31 | 17.73 |
Tangible Book Value | 467 | 876 | 283 | 50 | -155 | -590 |
Tangible Book Value Per Share | 1.91 | 3.59 | 1.16 | 0.23 | -0.86 | -3.25 |